March 27, 2007 / 6:26 AM / 11 years ago

Sanofi declines comment on possible BMS deal

PARIS (Reuters) - French pharmaceuticals group Sanofi (SASY.PA) on Tuesday declined comment on an article in Times newspaper suggesting the group was looking at a merger with Bristol-Myers Squibb (BMY.N).

    The spokesman however denied there was a divergence of views between chairman Jean-Francois Le Hecq and chief executive Gerard le Fur, as the Times reported.

    There have been regular rumors about a friendly tie-up between the two groups to create a global drugs giant.

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below